Publication | Closed Access

Conjugates of COL-1 monoclonal antibody and β-D-galactosidase can specifically kill tumor cells by generation of 5-fluorouridine from the prodrug β-D-galactosyl-5-fluorouridine

Tumor BiologyDrug TargetingProdrug β-D-galactosyl-5-fluorouridineImmunologyTumor CellsAntibody EngineeringImmunotherapeuticsAnti-cancer AgentTumor TargetingImmunotherapyMedicineRadiation OncologyCol-1 Monoclonal AntibodyCancer Research